grant

Task B16: Model Development and Medical Countermeasures (MCMs) for BSL-4 Agents in NHPs

Organization UNIVERSITY OF TEXAS MED BR GALVESTONLocation GALVESTON, UNITED STATESPosted 25 Jun 2024Deadline 24 Jun 2027
NIHUS FederalResearch GrantFY2024Contracting OpportunitiesContractsDevelopmentEbolaEvaluationdevelopmentalinfectious disease modelmedical countermeasuremodel developmentmodel developmentsnon-human primatenonhuman primatetherapeutic agent developmenttherapeutic development
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

This contract provides for the development of new and refinement of non-human primate models of infectious diseases and may include evaluation of candidate countermeasures.

Grant Number: 272201700040I-0-759302400002-1
NIH Institute/Center: NIH

Principal Investigator: DAVID BEASLEY

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Task B16: Model Development and Medical Countermeasures (MCMs) for BSL-4 Agents in NHPs — UNIVERSITY OF TEXAS MED BR GAL | Dev Procure